Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.080
+0.030 (2.86%)
At close: Dec 20, 2024, 4:00 PM
1.140
+0.060 (5.56%)
After-hours: Dec 20, 2024, 7:58 PM EST
Dermata Therapeutics Employees
Dermata Therapeutics had 8 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,408,812
Market Cap
2.20M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 1 | 14.29% |
| Dec 31, 2020 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Venus Concept | 304 |
| cbdMD | 52 |
| Aptevo Therapeutics | 40 |
| Biodexa Pharmaceuticals | 21 |
| Cyclacel Pharmaceuticals | 12 |
| Bluejay Diagnostics | 10 |
| Palisade Bio | 9 |
| Salarius Pharmaceuticals | 2 |
DRMA News
- 5 days ago - Dermata Receives Approval from FDA for the Proprietary Name Xyngari(TM) - Accesswire
- 11 days ago - Dermata Receives Notice of Allowance for New U.S. Patent for DMT310 for the Treatment of Acne - Accesswire
- 18 days ago - Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne - Accesswire
- 5 weeks ago - Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results - Accesswire
- 5 weeks ago - Dermata Therapeutics to Present at the Life Sciences Investor Forum on Thursday, November 14, 2024 - GlobeNewsWire
- 2 months ago - Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024 - Accesswire
- 3 months ago - Dermata Therapeutics Announces Closing of $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Accesswire
- 3 months ago - Dermata Therapeutics Announces $3.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Accesswire